Stanford University
Showing 2,101-2,120 of 2,414 Results
-
Jeffrey Teuteberg
Professor of Medicine (Cardiovascular Medicine)
On Leave from 12/15/2025 To 12/14/2027BioHe is currently a Professor of Medicine at Stanford, but is no longer seeing patients as he is on leave and working with industry.
His research interests are in clinical outcomes in patients after transplant and mechanical support as well as novel approaches to immunosuppression. He has participated in many single-center and multi-institutional research studies and has published widely in the fields of transplant and mechanical support. He served as President of the International Society of Heart and Lung Transplantation in 2018. -
Winifred Teuteberg
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Teuteberg completed residency training in Internal Medicine at the University of Chicago and a Palliative Medicine Fellowship at Massachusetts General Hospital. She joined the faculty at Stanford in 2017 and currently sees patients as a part of the inpatient palliative care consult team at Stanford Healthcare.
She has been the clinical director or Stanford Medicine's implementation of the Ariadne Labs' Serious Illness Care Program since its inception in 2018. Her interests include communication skills training, leveraging predictive algorithms to identify patients who would most benefit from serious illness conversations, how to empower non-physician clinical team members to participate in this work, and best practice for EHR builds related to advance care planning. -
Haluk Tezcan, MD
Adjunct Clinical Associate Professor, Medicine - Oncology
BioClinical focus:
Breast Oncology
Molecular Diagnostics
Dr. Tezcan is a medical oncologist and hematologist with over three decades of diverse experience in cancer management and research.
He is leading the clinical development of Droplet Biosciences' novel liquid biopsy technology, a first-in-class lymphatic fluid molecular residual disease assessment, overseeing the scientific and clinical development of the technology. With over three decades of direct patient care and clinical trial experience as a principal investigator and director, both in academia and private practice, he has a firsthand understanding of the unmet clinical needs of physicians and patients, as well as broad experience in clinical trial design and implementation.
He is also co-principal at Athea Oncology, guiding practices and hospitals in developing clinical trial programs and high-value real-world data collection and diagnostic companies in clinical development. He is also a reviewer of JCO Precision Medicine.
Before joining Athea Oncology and Droplet Biosciences, he was the co-founder of LexentBio, which was successfully acquired by Roche/FMI. He also served as Director of Translational Medicine at Genomic Health and as Vice President, leading oncology development at Counsyl, where he integrated science with clinical product development. He established the CA.RE.foundation, a cancer research foundation dedicated to enabling the execution of clinical trials across community oncology sites throughout the Northwest US. He has independently built multiple software tools to help oncologists navigate the practical realities of their daily work. -
Sonoo Thadaney Israni
Executive Director, Presence + Program in Bedside Medicine, Med/Program/Bedside Med
Current Role at StanfordExecutive Director, Presence (med.stanford.edu/presence.html) & Program in Bedside Medicine/Stanford 25 (stanfordmedicine25.stanford.edu)
Instructor Stanford University School of Medicine - Authentic Courage for Constructive Change: Skills and Practice for Leadership
LinkedIn Profile: www.linkedin.com/in/sonoo/ -
Julie Ngoc Thai, MD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Thai is a fellowship-trained specialist in geriatric medicine. She provides care at the Stanford Senior Care Clinic.
She completed her fellowship training at the University of California, San Francisco. She is board-certified in family medicine through the American Board of Family Medicine .
Dr. Thai earned her medical degree from Michigan State University College of Human Medicine. She completed her residency in family medicine at McLaren Flint/Michigan State University College of Human Medicine where she served as chief resident.
She also holds a Master of Public Health degree from Columbia University.
Dr. Thai has a background in clinical and population health research. She recently received a grant from the Blue Cross Blue Shield of Michigan Foundation to study the role of motivational interviewing in smoking cessation.
She contributed to research in rheumatoid arthritis, lupus, and ankylosing spondylitis in the Division of Rheumatology, Department of Medicine at Cedars Sinai Medical Center.
Dr. Thai was also an endourology research fellow in the Department of Urology at Mount Sinai Health System. Research focused on renal stone disease, clinical markers and outcomes, and testing and development of new technologies.
She has co-authored articles on topics such as caregivers’ communication with elders living with late-life disability, palliative care practices in diverse settings, and the social consequences of forgetfulness and Alzheimer’s disease. These articles appeared in the American Journal of Hospice and Palliative Medicine, Journal of Palliative Medicine, Journal of Mental Health Aging, and other peer-reviewed journals
Dr. Thai is a member of the American Geriatrics Society, American Academy of Family Physicians, and California Academy of Family Physicians. She is also an inductee of the Alpha Omega Alpha Honor Medical Society.
She has volunteered with homeless shelters, women’s advocacy groups, Goodwill, the American Red Cross, and AmeriCorps.
Dr. Thai is fluent in English and proficient in speaking Vietnamese. -
Lindsay Thomas, RN, MS, CNS
Affiliate, Medicine - Med/Cardiovascular Medicine
BioMs. Lindsay Thomas earned her BA in Integrative Biology from UC Berkeley in 2003 and her RN and MS from UCSF in 2006 and 2009 respectively. She completed a Double Master’s in Cardiovascular Nursing and Genomics and is a board certified clinical nurse specialist in critical care nursing. She joined the Stanford Interventional Cardiology Team in 2011 where she has pioneered the advanced practice nursing role in the cath lab and been a leader in the development of the Left Atrial Appendage Closure program. She serves as adjunct faculty for the UCSF graduate nursing program and is the co-chair of the Northern California Chapter of the Preventative Cardiovascular Nurses Association. Lindsay specializes in treating and caring for patients with established coronary artery disease and cardiovascular risk factors; she strives to provide excellent patient care and education to optimize a heart healthy life style to promote wellness with use of medications and invasive procedures when life style alone is not enough to achieve desired results. When not working Lindsay is an outdoor and exercise enthusiast, who enjoys participating in various endurance activities and has completed several triathlons. She also enjoys reading and discussions with her book club, going to the theater, and spending quality time with her friends and family.
-
Larry W. Thompson, Ph.D.
Professor (Research) of Medicine (Endocrinology, Gerontology, and Metabolism), Emeritus
Current Research and Scholarly InterestsDr. Thompsons interests include psychosocial treatments for individuals with bipolar disorder and /or other serious mental illnesses; cognitive/behavioral therapy for late-life depression; intervention research with culturally diverse individuals with depression; and psychophysiological research on stress & coping.
-
Stefan Thottunkal
Casual Employee, Med/Quantitative Sciences Unit
Casual Employee, Medicine - Primary Care and Population HealthBioStefan Thottunkal is a physician in training, Stanford researcher, and policymaker whose work sits at the intersection of artificial intelligence, precision medicine, translational science, and public health innovation. He completed the M.S. in Community Health and Prevention Research at Stanford University as an IIE Quad Fellow, one of the world’s most selective international research fellowships, where his thesis centered on computational pharmacogenomics and the use of data-driven LLM methods to advance precision prescribing.
His research focuses on translating innovation into clinically meaningful and implementation-ready health solutions, with particular interests in pharmacogenomics, chronic disease, and AI-enabled decision support. He is especially interested in how machine learning and large language models can be used not simply as technical advances, but as robust clinical tools that improve prescribing, strengthen care delivery, and incorporate human centered design principles to effectively integrate precision medicine in routine clinical practice.
At Stanford, he contributes to the Han Lab’s research on advancing precision oncology in advanced non-small cell lung cancer, while helping lead NOURISH, a pioneering Stanford Medicine initiative reimagining cardiometabolic care through culturally tailored nutrition science, behavioral insight, and digital innovation. NOURISH advances a model of lifestyle medicine that preserves cultural relevance while applying rigorous scientific methods to improve metabolic health. By integrating culinary medicine with emerging technologies, the initiative is exploring how AI-enabled tools, personalized digital education, and interactive nutrition support systems can make evidence-based dietary guidance more adaptive, engaging, and scalable across diverse populations. His work in this space reflects a broader interest in how technology can help transform nutrition care from generic advice into a more personalized, culturally tailored, and behaviorally attuned form of preventive medicine.
In parallel with his research career, Stefan brings close to half a decade of experience advising the Australian Federal Government on major health and social policy initiatives. His international experience also includes mentoring hackathon teams in India and medical device development in Nigeria, where he contributed to dialysis device innovation and clinical trials design in resource-constrained settings. Together, these experiences reflect his broader commitment to advancing equitable, evidence-based, and culturally tailored global health innovation. -
Kumar Thurimella
Resident in Medicine
BioI am an Internal Medicine resident at Stanford in the Translational Investigator Program (TIP), with a planned fellowship in Rheumatology.
I worked as a software engineer at Uber before completing my PhD at the University of Cambridge as a Gates Scholar and my MD at the University of Colorado. My research sits at the intersection of computational biology and B cell immunology, using protein language models and structural AI to identify novel therapeutic targets in autoantibody-mediated diseases.
Outside the clinic and lab, I enjoy skiing, hiking, biking, and reading science fiction.
